NCT06200584View on ClinicalTrials.gov

Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics

NACompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 1, 2021

Study Completion Date

June 10, 2021

Conditions

Antipsychotics and Neuroleptics Toxicity

Interventions

DRUG

Risperidone

Antipsychotic Agent

DRUG

Olanzapine

Antipsychotic Agent

DRUG

Quetiapine

Antipsychotic Agent

DRUG

Risperidone and Vitamin D and Vitamin E

vitamin

DRUG

Olanzapine and Vitamin D and Vitamin E

vitamin and Antipsychotic agent

DRUG

Quetiapine and Vitamin D and Vitamin E

Vitamin and Antipsychotic agents

Trial Locations (1)

75510

Jinnah Post Graduate Medical Centre, Karachi

All Listed Sponsors

lead

Dr Rabia Arshad

OTHER

NCT06200584 - Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics | Biotech Hunter | Biotech Hunter